NDC 0781-5175 – Mycophenolate Mofetil
Mycophenolate Mofetil 500 mg/1 · Tablet, Film Coated · Oral
Product NDC0781-5175
Product details
- Brand name
- Mycophenolate Mofetil
- Generic name
- Mycophenolate Mofetil
- Labeler
- Sandoz Inc
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA065451
- Marketed since
- October 15, 2008
- Listing expires
- December 31, 2026
- Pharmacologic class
- Antimetabolite Immunosuppressant
Active ingredients
- Mycophenolate Mofetil 500 mg/1
Uses, dosage, side effects and warnings for Mycophenolate Mofetil →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 0781-5175-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0781-5175-01) | Oct 15, 2008 |
| 0781-5175-05 | 500 TABLET, FILM COATED in 1 BOTTLE (0781-5175-05) | Oct 15, 2008 |
| 0781-5175-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (0781-5175-10) | Oct 15, 2008 |
Other Mycophenolate Mofetil products
- 50090-4275 Mycophenolate Mofetil 500 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 60687-438 Mycophenolate Mofetil 500 mg/1 · Tablet, Film Coated · American Health Packaging
- 71610-033 Mycophenolate Mofetil 500 mg/1 · Tablet, Film Coated · Aphena Pharma Solutions - Tennessee, LLC
- 67877-225 Mycophenolate Mofetil 500 mg/1 · Tablet, Film Coated · Ascend Laboratories, LLC
- 59651-638 Mycophenolate Mofetil 500 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 73190-010 Mycophenolate Mofetil 500 mg/1 · Tablet, Film Coated · AvKARE
- 50268-558 Mycophenolate Mofetil 500 mg/1 · Tablet, Film Coated · AvPAK
- 31722-879 Mycophenolate Mofetil 500 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 55154-3571 Mycophenolate Mofetil 500 mg/1 · Tablet, Film Coated · Cardinal Health 107, LLC
- 23155-836 Mycophenolate Mofetil 500 mg/1 · Tablet, Film Coated · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 0904-7078 Mycophenolate Mofetil 500 mg/1 · Tablet, Film Coated · Major Pharmaceuticals
- 68071-3767 Mycophenolate Mofetil 500 mg/1 · Tablet, Film Coated · NuCare Pharmaceuticals, Inc.